DMAE (Dimethylaminoethanol) is also known as 2-(dimethylamino)ethanol, beta-dimethylaminoethyl alcohol and N, N-dimethyl-2-hydroxy ethylamine. It is abbreviated DMAE. When deanol was on the market as a drug, it was called Deaner and was in the form of deanol acetamidobenzoate. Deanol is itself a liquid. The most common form of deanol supplement is deanol bitartrate.
DMAE (Dimethylaminoethanol) is a chemical naturally produced in the human brain. It is thought to be used by the body in converting choline to the neurotransmitter, acetylcholine (i.e., it is a precursor to acetylcholine). This is the basis for thinking that supplementing with DMAE will enhance brain activity.
For years dimethylaminoethanol was used to treat children with hyperactivity disorders. In addition to decreased hyperactivity, therapy with DMAE also reportedly produces increased attention span and decreased irritability which may enhance school performance and test scores in some children. DMAE may be helpful in the treatment of Alzheimer’s disease or senile dementia. However, research supporting this clinical application is weak. Studies have not shown an improvement in memory and cognitive function. DMAE would be more likely to provide benefits in patients with mild to moderate Alzheimer's symptoms rather than advanced cases.
DMAE may also provide some benefit in patients with tardive dyskinesia. Tardive dyskinesia is a movement disorder involving the face, jaw, tongue as well as the trunk and other extremities. It usually occurs after using certain antipsychotics for several weeks.